Novolin r and Exjade drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Novolin r (insulin recombinant purified human) and Exjade (deferasirox). Common drug interactions include blood creatinine increased among females and rash maculo-papular among males.

The phase IV clinical study analyzes what interactions people have when they take Novolin r and Exjade. It is created by eHealthMe based on reports of 23 people who take the same drugs from the FDA, and is updated regularly.

What is Novolin r?

Novolin r has active ingredients of insulin recombinant purified human. It is often used in type 1 diabetes. eHealthMe is studying from 4,568 Novolin r users. Check the latest studies of Novolin r.

What is Exjade?

Exjade has active ingredients of deferasirox. It is often used in iron overload. eHealthMe is studying from 29,456 Exjade users. Check the latest studies of Exjade.



On Jul, 26, 2026

23 people who take Novolin r and Exjade together, and have interactions are studied.

Novolin r and Exjade drug interactions.

What are the common drug interactions of Novolin R and Exjade, by gender? *:

female:

  1. Blood creatinine increased
  2. Renal impairment (severely reduced kidney function)
  3. Dehydration (dryness resulting from the removal of water)
  4. Back pain
  5. Blood alkaline phosphatase increased
  6. Herpes zoster
  7. Pneumonia
  8. Pubis fracture
  9. General physical health deterioration (weak health status)
  10. Neutropenia (an abnormally low number of neutrophils)

male:

  1. Rash maculo-papular (red area on the skin that is covered with small confluent bumps)
  2. Malaise (a feeling of general discomfort or uneasiness)
  3. Platelet count decreased
  4. Pyrexia (fever)
  5. Vomiting
  6. White blood cell count decreased
  7. Arthralgia (joint pain)
  8. Blood chloride increased
  9. Blood creatinine increased
  10. Cardiac failure

What are the common drug interactions of Novolin R and Exjade, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Rash maculo-papular (red area on the skin that is covered with small confluent bumps)
  2. Malaise (a feeling of general discomfort or uneasiness)
  3. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  4. Haemoglobin decreased
  5. Platelet count decreased
  6. Pyrexia (fever)
  7. Vomiting
  8. White blood cell count decreased

20-29:

n/a

30-39:

  1. Aplastic anaemia (blood disorder in which the body's bone marrow doesn't make enough new blood cells)
  2. Blood creatinine increased
  3. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  4. Bronchopulmonary aspergillosis (lung disorder caused by aspergillus fungi)
  5. Disease progression
  6. Febrile neutropenia (fever with reduced white blood cells)
  7. Hyperamylasaemia (acute pancreatitis in which serum amylase is usually elevated more than 4-fold)
  8. Nausea (feeling of having an urge to vomit)
  9. Renal impairment (severely reduced kidney function)
  10. Stomatitis (inflammation of mucous membrane of mouth)

40-49:

n/a

50-59:

  1. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
  2. Bacterial infection
  3. Gastric ulcer haemorrhage (bleeding ulcer of stomach)
  4. Pulmonary embolism (blockage of the main artery of the lung)
  5. Respiratory failure (inadequate gas exchange by the respiratory system)
  6. Secondary hypertension (elevated blood pressure that results from an underlying, identifiable, often correctable cause)

60+:

  1. Blood creatinine increased
  2. Dehydration (dryness resulting from the removal of water)
  3. Sepsis (a severe blood infection that can lead to organ failure and death)
  4. Thrombocytopenia (decrease of platelets in blood)
  5. Urinary tract infection
  6. Blood urea increased
  7. Renal failure (kidney dysfunction)
  8. Cardiac failure congestive
  9. Death
  10. Arthralgia (joint pain)

What are the existing conditions these people have? *

  1. Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 12 people, 52.17%
  2. Oropharyngeal Pain: 3 people, 13.04%
  3. Neuropathy Peripheral (surface nerve damage): 3 people, 13.04%
  4. Nausea (feeling of having an urge to vomit): 3 people, 13.04%
  5. Myeloid Leukaemia (a type of cancer in which the bone marrow makes abnormal myeloblasts): 3 people, 13.04%
  6. Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 3 people, 13.04%
  7. High Blood Pressure: 2 people, 8.70%
  8. Hereditary Haemochromatosis (hereditary condition -excessive amounts of iron accumulate in the body tissues): 2 people, 8.70%
  9. Aplastic Anemia: 2 people, 8.70%

* Approximation only. Some reports may have incomplete information.

Do you take Novolin r and Exjade?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Novolin r and Exjade:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Novolin r:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Exjade:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Novolin r and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Exjade and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on insulin recombinant purified human and deferasirox (the active ingredients of Novolin r and Exjade, respectively), and Novolin r and Exjade (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: